Can tizanidine and methocarbamol (Robaxin) be taken together?

Can Tizanidine and Robaxin Be Taken Together?

These two medications can technically be combined, but this approach is not recommended based on current evidence and carries significant risks of additive CNS depression without proven benefit over monotherapy.

Key Evidence Against Combination Therapy

The most recent guideline evidence explicitly advises against using multiple muscle relaxants together. The 2020 JAGS guideline states that so-called muscle relaxants including methocarbamol (Robaxin) "do not directly relax skeletal muscle and have no evidence of efficacy in chronic pain" and are "not favored for chronic pain" in older adults 1. This same guideline identifies tizanidine as a preferred option for musculoskeletal disorders but makes no mention of combining it with other muscle relaxants 1.

Safety Concerns with Combined Use

Additive CNS Depression

Both medications carry significant CNS depressant effects:

• Tizanidine FDA labeling explicitly warns that "sedation may be additive when tizanidine is taken in conjunction with drugs (baclofen, benzodiazepines) or substances (e.g., alcohol) that act as CNS depressants" 2

• Methocarbamol (Robaxin) FDA labeling warns about "combined effects with alcohol and other CNS depressants" 3

• The combination would predictably increase risks of:

  • Severe sedation and somnolence
  • Dizziness and falls (particularly concerning in older adults)
  • Impaired mental alertness
  • Hypotension (especially with tizanidine)
  • Respiratory depression

Lack of Evidence for Superior Efficacy

A 2022 emergency department study found that skeletal muscle relaxants (including both tizanidine and methocarbamol) provided no improvement over placebo when added to NSAIDs for acute low back pain 4. The mean improvement scores were essentially identical across all muscle relaxants tested, with methocarbamol actually showing the lowest improvement (8.1 points) compared to placebo (10.5 points) and tizanidine (11.5 points) 4.

A 2004 systematic review concluded there is "insufficient evidence to determine the relative efficacy or safety" when comparing different muscle relaxants, and found "very limited or inconsistent data regarding the effectiveness of methocarbamol" 5.

Clinical Algorithm for Decision-Making

If a patient requires muscle relaxant therapy:

1. Choose ONE agent, not both

   • For acute musculoskeletal pain (<2 weeks): Consider tizanidine or cyclobenzaprine as monotherapy 6
   • For chronic pain: Avoid traditional muscle relaxants entirely; consider tizanidine only if other options have failed 1

2. If inadequate response to monotherapy:

   • Reassess the diagnosis rather than adding a second muscle relaxant
   • Consider alternative adjuvant analgesics (duloxetine, gabapentinoids, topical agents) 1
   • Address underlying pain mechanisms rather than stacking CNS depressants

3. Special populations requiring extra caution:

   • Older adults: Higher risk of falls, confusion, and delirium 1, 7
   • Patients on other CNS depressants (opioids, benzodiazepines, alcohol)
   • Those with renal impairment (tizanidine clearance reduced >50%) 2
   • Patients taking CYP1A2 inhibitors with tizanidine 8

Common Pitfalls to Avoid

• Don't assume "more is better": No evidence supports combining muscle relaxants for enhanced efficacy
• Don't overlook drug interactions: Tizanidine has significant interactions with CYP1A2 inhibitors (ciprofloxacin, fluvoxamine) causing severe hypotension 8
• Don't use methocarbamol for chronic pain: Evidence only supports short-term use (<2 weeks) for acute conditions 6, 1
• Don't forget monitoring: If tizanidine is used, monitor for hypotension, bradycardia, and sedation 2

Bottom Line

Select tizanidine OR methocarbamol as monotherapy if a muscle relaxant is truly indicated, but never combine them. The combination increases CNS depression risks without evidence of improved outcomes. For most patients with musculoskeletal pain, evidence-based alternatives like duloxetine, gabapentinoids, or topical agents are preferable to any muscle relaxant 1.